Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence
The Effect of Remote Monitoring and Support for Patients Suffering From Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence to Treatment
1 other identifier
interventional
300
0 countries
N/A
Brief Summary
Moma call center will provide unique service -Remote monitoring and support for mental health patients .The aim of this reserch is reducing hospitalization and improve adherence, by reaching out and there for monitoring very closely .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable schizophrenia
Started Feb 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2016
CompletedFirst Posted
Study publicly available on registry
January 28, 2016
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedFebruary 9, 2016
January 1, 2016
1.9 years
January 18, 2016
February 7, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
number of days of hospitalization
through study competion ,an average of 1 year.
Study Arms (2)
intervention group
EXPERIMENTALintervention for improvement of treatment adherence "Intervention group"- This group will be followed by the "MOMA" call center (By the MOMA nures every couple weeks and by the study coordinatore and the treating Doctor at special "visits" as the study required.) The group will be monitored according to number of parameters, including treatment Adherence.
control group
EXPERIMENTALtreatment as usual Control group- Treatment will continue as usual by the Doctor.(This group will allso be followed by the Study Coordinator at the same "visits" as the "Intervention group".The group will be monitored according to number of parameters, including treatment Adherence.
Interventions
intervention for improvement of adherence
The control group will be treated according to the usual stadard of care.
Eligibility Criteria
You may qualify if:
- Men \& women,
- age 18-60 ,
- "Maccabi Health service" patients with diagnosis of: schizophrenia, Schizo - effective or Bipolar Dis.
- Must have 30 days or more of hospitalization (during 3 years). Treated with psychiatric medication.
- Living independently or with a help of a caregiver.
- Is able to provide written informed consent.
You may not qualify if:
- Violent, or suicidal.
- Drug\\ Alcohol, addiction,
- End stage Disease (Cancer, ESRF act.)
- Non - in depended and without Care giver/legal guardian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assuta Hospital Systemslead
- Sheba Medical Centercollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Asaf B Caspi, MD
Sheba Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2016
First Posted
January 28, 2016
Study Start
February 1, 2016
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
February 9, 2016
Record last verified: 2016-01
Data Sharing
- IPD Sharing
- Will share